Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises HAKI Safety in connection with its divestment of Landqvist Mekaniska Verkstad to Opima
Mandate

Vinge advises HAKI Safety in connection with its divestment of Landqvist Mekaniska Verkstad to Opima

May 07, 2025 M&A

Landqvist Mekaniska Verkstad is a mechanical engineering company specialising in metal machining and contract manufacturing, primarily serving Swedish industries. In 2024, it had annual sales of approximately SEK 78 M and an operating profit of SEK 9 M. The divestment is a step in HAKI Safety's change of strategy from a conglomerate to the current industry group with a focus on safety products and solutions that aim to create safe conditions for everyone working in challenging environments. Having completed this divestment, HAKI Safey now consists entirely of operations within work zone safety, scaffolding systems, and digital and technical solutions.

Vinge's team consisted of Anna Edström and Johan Severinsson (M&A).

Related

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025